Eurogenerics Eurogenerics
  • Home
  • About Us
    • Our Company
    • Activities
    • Certification
    • Work With Us
    • International Publication
  • Our Products
  • Our Services
  • Contact Us
Virbez ®
Virbez ® 150 - TAB

Virbez ® 150 mg

Category: Irbesartan Tag: Angiotensin II Receptor Blocker

Irbesartan – Virbez ®

150 mg Tablet

DRP-5686

BELL-KENZ PHARMA INC.

  • Description
  • Additional information

Description

VIRBEZ ® is Irbesartan, an angiotensin II receptor (AT₁ subtype) antagonist. It blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively binding to the AT₁ angiotensin II receptor. Virbez is an orally active agent that does not require biotransformation into an active form. The oral absorption of Virbez is rapid and complete with an average absolute bioavailability of 60-80%. Following oral administration of Virbez, peak plasma concentrations are attained at 1.5-2 hours after dosing. Food does not affect the bioavailability of Virbez. The elimination half-life of Virbez averaged 11-15 hours.

Supplied in Alu-PVC Blister Pack of 10’s (Box of 30’s).

Additional information

Drug Type

CARDIOVASCULAR

Principal

The Acme Laboratories Ltd.

Registration Status

Registered

Related products

  • Kenzar ® 100

    Kenzar ® 100 mg

    Losartan Potassium
  • Kenzar ® Plus

    Kenzar ® Plus 50/12.5 mg

    Losartan Potassium + HCTZ
  • Veztenor ® 5-50

    Veztenor ® 5/50 mg

    Amlodipine + Losartan

← View all products

  • Home
  • About Us
  • Our Products
  • Careers
  • Our Services
  • Contact Us
Euro Generics International Philippines © 2018